Tecan Group AG (SWX:TECN)

Market Cap	2.41B
Revenue (ttm)	1.00B
Net Income (ttm)	101.34M
Shares Out	12.83M
EPS (ttm)	7.89
PE Ratio	23.82
Forward PE	24.41
Dividend	3.00 (1.60%)
Ex-Dividend Date	Apr 22, 2024

Volume	59,879
Average Volume	60,641
Open	188.20
Previous Close	189.50
Day's Range	185.40 - 189.30
52-Week Range	185.40 - 392.00
Beta	0.77
RSI	29.96
Earnings Date	Mar 12, 2025

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The compa...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 3,573
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: TECN

Financial Performance

In 2023, Tecan Group AG's revenue was 1.07 billion, a decrease of -6.11% compared to the previous year's 1.14 billion. Earnings were 132.08 million, an increase of 9.04%.